A specially designed drug prevented laboratory mice from developing heart failure after heart attacks, according to new ...

Heart failure resulting from treatments for non-cardiac medical conditions presents a significant challenge in clinical ...

The US Food and Drug Administration (FDA) has approved the abbreviated new drug application (ANDA) of Lupin’s Sacubitril and ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Diabetic cardiomyopathy (DCM) is a specific type of cardiomyopathy that is independent of hypertension and ...

Around 20 million Americans reportedly trust this medication—here are the recall details, and the unusual error that caused ...

Type 2 diabetes is common; it affects one in ten adults internationally and one in five adults aged 65 years or older. It is ...

A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side effects.

If you are one of those who pop painkillers all too often, then you might be raising your risk of heart attack and heart ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

The message is that an early decrease in eGFR with finerenone should not lead to stopping the medication, say HF experts.

Here we take a look back at some of our research breakthroughs of 2024. January: Diet in childhood linked to blood vessel ...